Peter W Marks

21PUBLICATIONS
63CO-AUTHORS
Motor controlMolecular targetsStructural properties of condensed matterEmergency medicinePredictive and prognostic markers
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (21)

|Jun 16, 2023
Synergistic Strategies to Accelerate the Development of Function-Promoting Therapies: Lessons From Operation Warp Speed and Oncology Drug Development.

Rosaly Correa-de Araujo, William J Evans, Roger A Fielding

|Jan 25, 2023
Biological therapies need definitive randomized controlled clinical trials.

Robert M Califf, Peter W Marks

|Mar 18, 2022
Early administration of COVID-19 convalescent plasma with high titer antibody content by live viral neutralization assay is associated with modest clinical efficacy.

Artur Belov, Yin Huang, Carlos H Villa

|Dec 20, 2021
Access to and safety of COVID-19 convalescent plasma in the United States Expanded Access Program: A national registry study.

Jonathon W Senefeld, Patrick W Johnson, Katie L Kunze

|Aug 12, 2021
Mortality in individuals treated with COVID-19 convalescent plasma varies with the geographic provenance of donors.

Katie L Kunze, Patrick W Johnson, Noud van Helmond

|Apr 14, 2021
Program and patient characteristics for the United States Expanded Access Program to COVID-19 convalescent plasma.

Jonathon W Senefeld, Patrick W Johnson, Katie L Kunze

Pageof 4

Frequent Collaborators

4 joint publications

Rickey E Carter

4 joint publications

Jonathon W Senefeld

4 joint publications

Philippe R Bauer

4 joint publications

Arturo Casadevall